Search - tctmd.com

Displaying 121 - 140 of 483

Sort: Relevancy | Date

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

News Daily News

Uncomplicated TLR After PCI Linked With Worse Mortality

Michael O'Riordan

April 20, 2018

Presentation SCAI 2018

How to treat: Recurrent In-stent Restenosis

Presenter: Kenneth Chin

March 23, 2018

News Daily News

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

Yael L. Maxwell

February 26, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

Presentation CHIP Florida 2018

In-stent Restenosis Due to Underexpanded Stent

Presenter: Nirat Beohar

January 22, 2018

Presentation CHIP Florida 2018

Recalcitrant In-stent Restenosis

Presenter: Jeffrey W. Moses

January 19, 2018

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

Presentation

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

July 19, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

Advertisement

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Uncomplicated TLR After PCI Linked With Worse Mortality

How to treat: Recurrent In-stent Restenosis

FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

SELUTION™ First-in-Man Study Achieves Primary Endpoint

In-stent Restenosis Due to Underexpanded Stent

Recalcitrant In-stent Restenosis

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Slimmest Stent to Date Looks Promising in Small Study

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content